AO
Abraham N. Oler
SVP Corp Dev & Gen Counsel

Abraham N. Oler insider trades: Onconova Therapeutics (ONTX) stock purchases

SVP Corp Dev & Gen Counsel, Onconova Therapeutics Last trade Jan 28, 2022 17 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2019
1
Company
last trade 2022

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Abraham reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jan 28, 2022ONTX↑ Buy$3K
Jan 21, 2022ONTX↑ Buy$3K
Jan 14, 2022ONTX↑ Buy$3K
Jan 7, 2022ONTX↑ Buy$4K
Nov 19, 2021ONTX↑ Buy$3K
Sep 28, 2021ONTX↑ Buy$10K
Feb 16, 2021ONTX↑ Buy$12K
Dec 11, 2020ONTX↑ Buy$10K
Nov 25, 2020ONTX↑ Buy$5K
May 19, 2020ONTX↑ Buy$6K
Nov 25, 2019ONTX↑ Buy$15K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Abraham N. Oler's insider trades

Abraham N. Oler is SVP Corp Dev & Gen Counsel at Onconova Therapeutics (ONTX). Since Nov 25, 2019, Abraham has reported 11 open-market purchases worth $73K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (5 filings), option exercises (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ONTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.